Home / Inspections / 1168201

FDA Inspection 1168201 — Wyeth Pharmaceutical Division of Wyeth Holdings LLC

Wyeth Pharmaceutical Division of Wyeth Holdings LLC — FEI 2410662

The FDA completed an inspection of Wyeth Pharmaceutical Division of Wyeth Holdings LLC on April 13, 2022 in Pearl River, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 13, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pearl River, NY (United States)

Facility

Other inspections at this facility

  • 1295786 (VAI Wed Dec 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1237528 (VAI Wed Aug 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 804865 (VAI Wed Oct 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 791692 (NAI Wed Jul 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 597355 (NAI Wed Jul 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources